Cases in the United States

Cancer Clinical Trials United States

NCI has transformed its clinical research programs to keep pace with advances in the scientific understanding of cancer. With the creation of the National Clinical Trials Network and NCI Community Oncology Research Program, systemic changes are in place that will improve cancer research and lead to improvements in care for the 1.6 million Americans diagnosed with cancer every year.

  • National Clinical Trials Network (NCTN)
    NCTN is a new clinical trials research network that provides an infrastructure for NCI treatment, screening, and diagnosis trials. The new infrastructure allows investigators to begin clinical trials more quickly, reach conclusions faster, and offer patients studies that incorporate precision medicine at over 3, 000 clinical trials sites.
  • NCI Community Oncology Research Program (NCORP)
    NCORP is a community-based program that builds upon the scope and activities of NCI's previously supported community networks: the NCI Community Clinical Oncology Program (CCOP) and NCI Community Cancer Centers Program (NCCCP). The program brings cancer clinical trials, as well as cancer care delivery research (CCDR), to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.

While NCI’s clinical research programs are changing, the Institute remains committed to every patient enrolled in an NCI-funded clinical trial and will ensure that they continue to have the opportunity to receive the full benefit of those trials.

Learn more about the changing landscape of NCI clinical trials below.

NCI Approves Funding Plan for NCI Community Oncology Research Program (NCORP) (June 25, 2014)
Scientific program leaders at NCI have approved a funding plan for the NCI Community Oncology Research Program (NCORP).

Teleconference Summary: NCI Clinical Trials Systems (May 16, 2014)
A summary of the opening remarks given by NCI leadership during a teleconference for the advocacy community highlighting changes to the NCI clinical trials enterprise.

Open Letter to the Cancer Community Regarding Community Clinical Trials (April 10, 2014)
Harold Varmus reaffirms NCI’s commitment to patients in community clinical trials and explains the transition from the CCOPs and the NCCCP to a new network, NCORP.

Statement on Forthcoming Changes in NCI’s Clinical Trials Programs (April 4, 2014)
An overview explaining the need for clinical trials reform and specific components of the system.

Implementation of the NCI’s National Clinical Trials Network (March 20, 2014)
An NCI Perspective Article that explains the goals that will guide the new clinical trials system and how the changes will enhance NCI-supported clinical trials.

Other NCI Programs That Sponsor or Conduct Clinical Trials

NCI supports clinical research in many ways, beyond just the NCTN and NCORP. Numerous other programs directly or indirectly support clinical research.

BMC Medical Research Methodology at the 35th Annual Conference of the ..  — BMC Pediatrics
The conference will focus on issues such as design and analysis of clinical trials, methods in biostatistics and development of clinical prediction models.

Chapman and Hall/CRC Randomized Phase II Cancer Clinical Trials (Chapman & Hall/CRC Biostatistics Series)
Book (Chapman and Hall/CRC)
  • Used Book in Good Condition

Popular Q&A

avatar
Who is going to "candidate trial" the swine flu vaccine?

America says that the swine flu vaccine will be ready soon but they need to "trial a first candidate" for a few months to make sure it is safe.
Are the British public going to be the "candidates" for this trial as the government says the vaccine will be available here at the end of August.
On Wednesday, World Health Organisation (WHO) chief Margaret Chan warned that a vaccine to combat the swine flu pandemic would not be readily available for several months.

Its obvious they are trying to put the fear into people, so as soon as the vaccination becomes available, people will be queuing up to get it, falsely thinking that it will 'protect' them, then if they get any symptoms, this will be blamed on the 'virus'. Very clever tactic, by a multi billion pound organization. I heard on the news yesterday they've been preparing for this for 2 years.
Its obvious they are trying to create a major pandemic!
The thing that worries me the most is that they may make the vaccination mandatory. Then people who choose not to take it will be 'looked down …

Related Posts